Long-term Extension Study of Ulviprubart (ABC008) in Subjects With Inclusion Body Myositis
Clinical trial NCT06450886 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06450886
- Sponsor
- Abcuro, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-21
- Primary completion
- 2029-01-01
- Enrollment
- 270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.